![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessThe Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer
Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate cancer (PCa) that has become a major challenge in clinics. Understanding the neuroendocrine differentiation (NED) process at the m...
-
Chapter
Hypoxia: A Formidable Saboteur of the Anti-tumor Response
The tumor microenvironment (TME) promotes neoplastic transformation, supports tumor growth and invasion, protects the tumor from host immunity and fosters therapeutic resistance. It is well established that tu...
-
Article
Open AccessHedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Castration resistant prostate cancer (CRPC) develops as a consequence of hormone therapies used to deplete androgens in advanced prostate cancer patients. CRPC cells are able to grow in a low androgen environm...
-
Article
The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?
The nuclear factor of kappa beta (NF-κB) transcription factor regulates the transcription of numerous genes including that of interleukin 6 (IL-6). The IL-6 acts as an autocrine and paracrine growth factor of ...